Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 5045182, 10 pages
https://doi.org/10.1155/2018/5045182
Research Article

Vildagliptin Can Alleviate Endoplasmic Reticulum Stress in the Liver Induced by a High Fat Diet

Xiaoqing Ma,1,2,3,4 Wenhua Du,1,2,3,5 Shanshan Shao,1,2,3 Chunxiao Yu,1,2,3 Lingyan Zhou,6 and Fei Jing1,2,3

1Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
2Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism, Jinan, Shandong 250021, China
3Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Jinan, Shandong 250021, China
4Department of Endocrinology, Jining No. 1 People’s Hospital, No. 6 Health Road, Rencheng, Jining 272011, China
5Department of Endocrinology, Linyi People’s Hospital, Linyi, Shandong 276001, China
6Department of Endocrinology, The Second Hospital of Shandong University, No. 247 Beiyuan Street, Jinan 250033, China

Correspondence should be addressed to Fei Jing; moc.361@5170iefgnij

Received 4 September 2017; Accepted 13 December 2017; Published 12 March 2018

Academic Editor: Kusum Kharbanda

Copyright © 2018 Xiaoqing Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Itou, T. Kawaguchi, E. Taniguchi, and M. Sata, “Dipeptidyl peptidase-4: a key player in chronic liver disease,” World Journal of Gastroenterology, vol. 19, no. 15, pp. 2298–2306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Nathan, “Finding new treatments for diabetes—how many, how fast... How good?” The New England Journal of Medicine, vol. 356, no. 5, pp. 437–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Russell, “Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction,” International Journal of Clinical Pharmacy, vol. 35, no. 2, pp. 159–172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. P. A. Read, F. Z. Khan, P. M. Heck, S. P. Hoole, and D. P. Dutka, “DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease,” Circulation: Cardiovascular Imaging, vol. 3, no. 2, pp. 195–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Huisamen, A. Genis, E. Marais, and A. Lochner, “Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats,” Cardiovascular Drugs and Therapy, vol. 25, no. 1, pp. 13–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. G. P. Fadini and A. Avogaro, “Cardiovascular effects of DPP-4 inhibition: beyond GLP-1,” Vascular Pharmacology, vol. 55, no. 1–3, pp. 10–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. N. Ta, Y. Li, C. A. Schuyler, M. F. Lopes-Virella, and Y. Huang, “DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes,” Atherosclerosis, vol. 213, no. 2, pp. 429–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Shirakawa, H. Fujii, K. Ohnuma et al., “Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice,” Diabetes, vol. 60, no. 4, pp. 1246–1257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kern, N. Klöting, H. G. Niessen et al., “Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity,” PLoS ONE, vol. 7, no. 6, Article ID e38744, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ohyama, K. Sato, Y. Yamazaki et al., “MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice,” World Journal of Gastroenterology, vol. 20, no. 43, pp. 16227–16235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. R. Aroor, J. Habibi, D. A. Ford et al., “Dipeptidyl peptidase-4 inhibition ameliorates western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function,” Diabetes, vol. 64, no. 6, pp. 1988–2001, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Macauley, K. G. Hollingsworth, F. E. Smith et al., “Effect of vildagliptin on hepatic steatosis,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 4, pp. 1578–1585, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Kato and H. Nishitoh, “Stress responses from the endoplasmic reticulum in cancer,” Frontiers in Oncology, vol. 5, article no. 93, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Sozen, B. Karademir, and N. K. Ozer, “Basic mechanisms in endoplasmic reticulum stress and relation to cardiovascular diseases,” Free Radical Biology & Medicine, vol. 78, pp. 30–41, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Sano and J. C. Reed, “ER stress-induced cell death mechanisms,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1833, no. 12, pp. 3460–3470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. W. Park and U. Ozcan, “Potential for therapeutic manipulation of the UPR in disease,” Seminars in Immunopathology, vol. 35, no. 3, pp. 351–373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A.-H. Lee, E. F. Scapa, D. E. Cohen, and L. H. Glimcher, “Regulation of hepatic lipogenesis by the transcription factor XBP1,” Science, vol. 320, no. 5882, pp. 1492–1496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Oyadomari, H. P. Harding, Y. Zhang, M. Oyadomari, and D. Ron, “Dephosphorylation of translation initiation factor 2α enhances glucose tolerance and attenuates hepatosteatosis in mice,” Cell Metabolism, vol. 7, no. 6, pp. 520–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Hamamoto, Y. Kanda, M. Shimoda et al., “Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes,” Diabetes, Obesity and Metabolism, vol. 15, no. 2, pp. 153–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. L. Kammoun, H. Chabanon, I. Hainault et al., “GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice,” The Journal of Clinical Investigation, vol. 119, no. 5, pp. 1201–1215, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Ji, Z. Zhao, T. Cai, P. Yang, and M. Cheng, “Liraglutide alleviates diabetic cardiomyopathy by blocking CHOP-triggered apoptosis via the inhibition of the IRE-α pathway,” Molecular Medicine Reports, vol. 9, no. 4, pp. 1254–1258, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Liu, Y. Liu, L. Chen, Y. Wang, and J. Li, “Glucagon-like peptide-1 analog liraglutide protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway,” Journal of Diabetes Research, vol. 2013, Article ID 630537, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Zhao, H. Guo, H. Chen et al., “Effect of Liraglutide on endoplasmic reticulum stress in diabetes,” Biochemical and Biophysical Research Communications, vol. 441, no. 1, pp. 133–138, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-A. Jung, Y.-K. Choi, G.-S. Jung et al., “Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis,” Diabetes Research and Clinical Practice, vol. 105, no. 1, pp. 47–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. J. G. Hatlebakk, F. Zerbib, S. Bruley des Varannes et al., “Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy,” Clinical Gastroenterology and Hepatology, vol. 14, no. 5, pp. 678–685.e3, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, “Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343–1351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Özcan, Q. Cao, E. Yilmaz et al., “Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes,” Science, vol. 306, no. 5695, pp. 457–461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. S. Hotamisligil, “Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease,” Cell, vol. 140, no. 6, pp. 900–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Esfandiari, J. A. Villanueva, D. H. Wong, S. W. French, and C. H. Halsted, “Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 289, no. 1, pp. G54–G63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. G. H. Werstuck, S. R. Lentz, S. Dayal et al., “Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways,” The Journal of Clinical Investigation, vol. 107, no. 10, pp. 1263–1273, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Liu, X. Jin, C.-H. Yu, S.-H. Chen, W.-P. Li, and Y.-M. Li, “Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis,” Journal of Gastroenterology and Hepatology, vol. 25, no. 3, pp. 613–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Ota, C. Gayet, and H. N. Ginsberg, “Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents,” The Journal of Clinical Investigation, vol. 118, no. 1, pp. 316–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Qiu, Q. Su, A. C. Rutledge, J. Zhang, and K. Adeli, “Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling,” Journal of Lipid Research, vol. 50, no. 9, pp. 1814–1823, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Nakatani, H. Kaneto, D. Kawamori et al., “Involvement of endoplasmic reticulum stress in insulin resistance and diabetes,” The Journal of Biological Chemistry, vol. 280, no. 1, pp. 847–851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Ben-Shlomo, I. Zvibel, M. Shnell et al., “Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase,” Journal of Hepatology, vol. 54, no. 6, pp. 1214–1223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. H. C. Hong, H. Hwang, H. J. Lee et al., “The dipeptidyl peptidase-IV inhibitor (gemigliptin) inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms,” Endocrine Abstracts, 2015. View at Publisher · View at Google Scholar
  37. H.-J. Hwang, T. W. Jung, J. Y. Ryu et al., “Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes,” Molecular and Cellular Endocrinology, vol. 392, no. 1-2, pp. 1–7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. H.-J. Hwang, T. W. Jung, B.-H. Kim et al., “A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression,” Biochemical Pharmacology, vol. 98, no. 1, pp. 157–166, 2015. View at Publisher · View at Google Scholar · View at Scopus